Monopost (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, promoting remodeling of the extracellular matrix and increasing uveoscleral outflow of aqueous humor. This enhanced outflow lowers intraocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Monopost is determined by the prescribing clinician based on the patient’s condition and response. Typically, a single drop is instilled in the affected eye(s) once daily in the evening, but exact instructions must come from a qualified eye‑care professional.

The safety of latanoprost in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the Monopost product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monopost (latanoprost) is a first‑line prostaglandin analog, often preferred for its once‑daily dosing and strong intraocular pressure‑lowering effect. Compared with beta‑blocker or carbonic anhydrase inhibitor eye drops, it typically offers greater efficacy with a different side‑effect profile, such as increased eyelash growth.

Monopost should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from light and moisture, and avoid freezing. Do not use the product if the solution becomes discolored or contaminated.

Monopost is applied as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac of the affected eye(s). Close the eye gently for a few seconds and avoid blinking excessively.

Serious risks, though rare, include severe eye inflammation (uveitis or iritis), allergic reactions such as swelling or rash around the eye, sudden vision loss, and ocular infection. Any sudden ocular discomfort or visual changes should prompt immediate medical evaluation.

Monopost is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation. It should also be avoided in individuals with active ocular infections or inflammation, and used with caution in those with a history of uveitis or severe ocular surface disease.